Short Description
Differentiates and quantifies cholesterol fractions (HDL vs. LDL/VLDL) with dual detection.
Development Stage
Research-Grade Lipid Metabolism Assay Development
Description
The LipidFlux™ AF HDL and LDL/VLDL Assay Kit supports the detailed segmentation of cholesterol carriers, enabling researchers to evaluate the cardiovascular safety and efficacy of lipid-modulating drugs. By distinguishing between high-density and low-density lipoproteins with high specificity, this assay aids in identifying potential risks associated with drug candidates. It is an essential component of comprehensive cardiovascular risk assessment panels in pre-clinical toxicology.
Features
Advanced fractionation capabilities allow distinct quantification of lipoprotein subclasses; Essential for detailed pharmacodynamic profiling of cardiovascular drugs.
Process Relevance
Lipid Metabolism Research
Application Stage
Pre-clinical Efficacy
Applications
Comprehensive lipid metabolic profiling and cardiovascular risk assessment.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 570 nm, or Fluorescence Detection (Ex 530 nm / Em 585 nm)
Research Areas
Cardiovascular Disease; Lipid Metabolism
Datasheet